REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharma To Market Pte. Ltd. (Singapore)

Main Activities: All Other Professional, Scientific, and Technical Services
Secondary Activities: Wholesale Trade
Full name: Pharma To Market Pte. Ltd. Profile Updated: December 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: other professional, scientific and technical activities n.e.c.; Secondary Business Activity: wholesale trade of a variety of goods without a dominant product

Legal Address
230 Victoria Street, #15-01/08, Bugis Junction Towers, Singapore 188024
Singapore; Singapore; Postal Code: 188024

Contact Details: Purchase the Pharma To Market Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma To Market Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Pharma To Market Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Pharma To Market Pte. Ltd. report to view the information.
Incorporation Date:
February 06, 2017
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Pharma To Market Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
8.24%▲
Total operating revenue
8.24%▲
Net Profit (Loss) for the Period
47.35%▲
Total Assets
26%▲
Total Equity
36.21%▲
Net Profit Margin
11.77%▲
Return on Equity (ROE)
4.43%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo